Evidence map›Paper›PMID 41699156›Full record

ArticleScientific reports2026

Brain tumor classification using optimized ResNet50 with dynamic precision optimization for enhanced speed and diagnostic accuracy.

Vahid Mehrdad, Reza Talebzadeh, Negin Fazaeli

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Vahid MehrdadDepartment of Electrical Engineering, Faculty of Engineering, Lorestan University, Khorramabad, Iran. mehrdad.v@lu.ac.ir.
Reza TalebzadehDepartment of Electrical Engineering, Faculty of Engineering, Lorestan University, Khorramabad, Iran.
Negin FazaeliDepartment of Electrical Engineering, Faculty of Engineering, Lorestan University, Khorramabad, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The detection and classification of brain tumors remain a major challenge in the medical field due to their morphological complexity. In this study, by optimizing a model from the ResNet family and applying architectural modifications, including the addition of specialized layers, an efficient system was designed that simultaneously reduced computational parameters, decreased training time, and increased inference speed, while improving diagnostic accuracy up to 99.69%. The proposed model, through the use of Transfer Learning (TL) and Fine-Tuning techniques, as well as the implementation of intelligent computational precision management, is capable of maintaining a balance between model complexity and operational accuracy, enabling deployment on resource-limited hardware. The model achieved 100% precision in detecting glioma, pituitary, and healthy cases, and 98.71% precision in identifying meningioma. To enhance the interpretability of results, the model's output was combined with a Random Forest (RF) classifier, allowing physicians to analyze the decision-making process and the key features influencing diagnosis. The experiments were conducted on the brain MRI dataset, comprising 7023 images categorized into four classes. The dataset was split into 80% training and 20% testing, and a 5-fold cross-validation strategy was also applied to ensure model generalization. The obtained results demonstrate the high efficiency, computational optimization, and clinical applicability of the proposed architecture in developing intelligent automated brain tumor diagnosis systems.

Indexed as

Brain NeoplasmsClassification AlgorithmsConvolutional Neural NetworksGliomaHumansMagnetic Resonance ImagingRandom ForestTransfer Machine LearningBrain Tumor DetectionDeep LearningMRI ImagesMulti-class ClassificationResNet50Transfer Learning

Identifiers

PMID41699156
PMCPMC13000198

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.